In the recurrence group, a significantly greater area of the entire tumor was positive for ITGB8 (p = 0.03), TGF-β1 (p = 0.05), and TGF-β1 LAP (p = 0.05, Figure 6B) compared with the non-recurrence group. This evidence concerns the gene TGFB1 and neoplasm.